LANXESS expands capacity of microbial active ingredient Preventol CMK by 50 percent

Long-term trend towards more disinfection

27-Jan-2022 - LANXESS is expanding its production capacity for the active ingredient Preventol CMK (chlorocresol) at the Krefeld-Uerdingen, Germany, site by around 50 percent in response to the continuing strong demand for disinfectants and industrial preservation. The specialty chemicals company has invested ...

LANXESS to acquire IFF’s microbial control business

Strengthening the specialty chemicals portfolio: expansion of the growth areas disinfection, personal care and material protection

25-Aug-2021 - LANXESS is taking another big step on its growth course: the specialty chemicals company intends to take over the microbial control business of the U.S. group International Flavors & Fragrances Inc. (IFF). Both companies signed a corresponding agreement on August 23, 2021. IFF Microbial Control ...

LANXESS plans to expand capacity for Oxone monopersulfate - a main active ingredient for disinfectants

Significant increase in demand due to African swine fever and corona pandemic

16-Sep-2020 - Due to the continuous strong demand for disinfectants, specialty chemicals company LANXESS is planning to expand its production capacity for Oxone monopersulfate by around 50 percent. To this end, the company intends to invest a lower double-digit million euro sum in its production facility in ...

Biotechnology for soaking and liming

14-Aug-2013 - The X-Zyme process launched by LANXESS is a technology for the beamhouse stage of the leather production process. “The use of two microbial enzymes in the soaking and liming noticeably improves the quality of the pelt, reduces the amount of waste and makes the entire process much more efficient,” ...

evocatal draws two new investors as it closes €3.5m Series B round

08-Jul-2013 - evocatal GmbH has completed a Series B financing round. All of the company's existing investors took part, along with new investors NRW.BANK and LANXESS. In realizing the next step of its growth strategy, evocatal has partnered with two new investors: LANXESS and NRW.BANK. The investments from ...

Saltigo undertakes major expansion of production

Syngenta invests around EUR 50 million in Saltigo facilities

06-May-2010 - Saltigo, a wholly owned subsidiary of LANXESS, is significantly expanding production at its Leverkusen site. This is being made possible by a cooperation agreement that is so far unique for the Group. Syngenta is investing some EUR 50 million in expanding several Saltigo facilities in Leverkusen ...

LANXESS disinfectant effective against swine flu viral strain

New study from Giessen University

02-Jul-2009 - A recent study carried out on behalf of LANXESS has demonstrated the effectiveness of the disinfectant Preventol CD 601 against the swine flu viral strain. “The test results from Giessen University show that Preventol CD 601 can also play a major role in the fight against swine flu, which has now ...